34results about How to "Improve clinical efficiency" patented technology

The invention discloses a traditional Chinese medicine extractive composition and a preparation method thereof, wherein the extractive composition is prepared from the following components: by weight, 42-62 parts of hedera helix extractive, 5-10 parts of Marian thistle extractive, 3-5 parts of olive leaf extractive, 6-12 parts of fennel extractive, 10-15 parts of liquorice extractive, 10-15 parts of radix ophiopogonis extractive, 10-15 parts of dried tangerine peel extractive, and 8-10 parts of radix polygonati officinalis. By a special technology, the hedera helix extractive, Marian thistle extractive, olive leaf extractive, fennel extractive, liquorice extractive, radix ophiopogonis extractive, dried tangerine peel extractive and radix polygonati officinalis of higher purities are obtained and combined by an optimal proportion. The composition has a good curative effect on cough; it is safe and nontoxic with remarkable curative effect, and without generating resistance to drugs; it clinical effective rate is up to 97%, and its cure rate is up to 92%.

The invention discloses a stent used for portal vein stenosis after liver transplantation in children, and belongs to the field of medical devices. A stent main body consists of a plurality of annularsupports distributed along an axial direction, and two adjacent annular supports are connected by at least one connector. The stent main body is divided into three parts: a proximal end, a middle part and a distal end, the pipe diameter of the middle part is the smallest, and the pipe diameter of the distal end is the largest. According to the present invention, the stent has the advantages thatthe stenosis of diseased vessels which is caused by pipe diameter mismatch and mainly concentrates on diameter changes is treated, the adhesion property of the vessel distal end and the expansion property of the vessel proximal end can be improved, and the physiological adaptability of the stent can be improved; the combined area and friction between the stent and a portal vein stent can be increased, the stability of the stent can be increased, and the incidence of stent displacement can be reduced; and the change of the portal vein intracavitary hemodynamics can be decreased, the risk of restenosis after stent implantation can be reduced, and the occurrence of adverse events can be decreased.

The present invention relates to complex salt or composition medicine of breviscapine and basic amino acid for treating cardiac and cerebral vascular diseases. The composition medicine consists of breviscapine 1 weight portions, and basic amino acid 0.01-100 weight portions, and proper amount of supplementary material. It may be prepared into powder for injection, injection, oral liquid, capsule and other suitable clinical preparation forms. The composition medicine of the present invention has obviously raised dissolubility and bioavailability of breviscapine, high medicine effect, obvious synergistic effect and wide clinical application foreground.

The invention provides a pharmaceutical composition and a kit for treating cancers. The pharmaceutical composition comprises an antibody resisting a programmed cell death receptor 1 and co-cultured dendritic cells and cytokine-induced killer cells; the kit comprises the antibody resisting a programmed cell death receptor 1 and an inducer of the co-cultured dendritic cells and cytokine-induced killer cells, which are separately arranged. The pharmaceutical composition or the kit can be effectively used for treating cancers, and particularly are applicable to treatment of advanced refractory solid tumors or hematological malignancy.

The invention discloses zileuton-containing membrane-controlled slow release pellets and a preparation method thereof. The zileuton-containing membrane-controlled slow release pellets contain quick release coated pellets and slow release coated pellets in a weight part ratio of 1:3-1:7, wherein the coated pellets consist of zileuton-containing medicated pellet cores and coatin layers wrapped outside the medicated pellet cores; and the weight part ratio of the medicated pellet cores to the coating layer is 5:1-15:1. The drup release rate of the zileuton-containing membrane-controlled slow release pellets is stable and controllable, and the clinical effectiveness is obviously improved; meanwhile, adverse effect occurrence of the gastrointestinal tract is also greatly reduced; and the pellets have a simple preparation process and high repeatability and are suitable for scale-up production.

The invention discloses a black rice health-preserving wine capable of tonifying kidney and producing sperm and a production method thereof, belonging to the technical field of health food brewage. The production method comprises the following steps: adding a traditional Chinese medicinal material extracting solution capable of tonifying kidney before aging and storing black rice wine, aging and storing, settling, filtering and sterilizing. The wine is prepared from the following raw materials in parts by weight: 100 parts of black rice wine, 1.0-1.5 parts of Diaphragma juglandis, 1.2-1.5 parts of radix astragali, 2.0-2.5 parts of Polygonatum sibiricum, 0.8-1.0 part of licorice, 0.5-0.9 part of American ginseng, 0.5-0.6 part of angelica, 0.6-0.9 part of orange peel, 0.6-0.9 part of skunk bugbane, 0.7-0.9 part of Bighead Atractylodes Rhizome, 0.4-0.5 part of ginger, 0.5-1.0 part of Chinese date and 0.5-1.0 part of Chinese wolfberry. The total flavone content in the produced black rice wine reaches 178.52 mg / 100ml. The clinical use proves that the black rice wine has obvious actions on dizziness, tiredness, waist soreness, leg pain and nocturia caused by deficiency and aging of the kidney, has no toxic or side effect, and is suitable for broad people.

The invention discloses external spleen and stomach strengthening and digestion promoting plaster. The external spleen and stomach strengthening and digestion promoting plaster is prepared from the following components of endothelium corneum gigeriae galli, flos caryophylli, fructus amomi, cortex cinnamomi, poria, cortex magnoliae officinalis, rhizoma atractylodis macrocephalae, rhizoma atractylodis, semen alpiniae katsumadai, radix aucklandiae, borneol, sodium benzoate and laurocapram. Pure natural raw materials are adopted, safe, efficient and high-quality products are developed through specific compatibility and process extraction treatment and a traditional Chinese medicine fermentation process, medicine taking and injection are avoided, and the external spleen and stomach strengthening and digestion promoting plaster can be effectively used for treating weakness of the spleen and the stomach, poor transportation and transformation functions, dyspepsia, anorexia, poor appetite andnon-inflammatory diarrhea, and is remarkable in effect, small in side effect, safe and effective. Children patients are pleasant to accept, and use and carry are convenient.

The invention belongs to the technical field of Chinese patent medicine and in particular relates to a drug for treating diabetes mellitus. The drug is prepared by taking agrimonia pilosa, radix ophiopogonis, radix astragali seu hedysari, fructus schisandrae, radix notoginseng, herba dendrobii, radix puerariae, rhodiola and radix trichosanthis as raw materials according to a conventional powder preparation method. The drug is specifically prepared through the steps of uniformly mixing all the medicines in parts by weight, grinding into fine powder with the size of 120 meshes, and sub-packaging. Other dosage forms are processed through concentrating on the basis of the powder. Theoretical and clinical tests show that the traditional Chinese medicine preparation for adjusting glucose metabolism, provided by the invention, is safe, has no toxin and has a remarkable curative effect; the drug also has the advantages of simplicity in preparation, wide medicine sources, low cost and the like, and particularly has a very good effect on the initial stage of diabetes mellitus. The clinical efficiency is up to 100 percent and the curing rate reaches 70 percent.

The invention discloses a Ligusticum wallichii-rhizoma atractylodis pill for treating depression syndrome. Raw materials of the pill comprise the following components: 6-8 g of rhizoma atractylodis, 6-8 g of Cyperus Rotundus L, 6-8 g of Ligusticum wallichii, 6-8 g of medicated leaven, 6-8 g of cape jasmine, 6-8 g of deep fried atractylodes and 6-8 g of Chinese angelica. The Ligusticum wallichii-rhizoma atractylodis pill for treating depression syndrome is simple and reasonable to prepare, has wide medicinal herbs resources, is low-cost, has remarkable curative effects, has no toxic or side-effect, promotes qi circulation and relieves depression, and can effectively treat depression syndrome. Clinical application efficiency of the Ligusticum wallichii-rhizoma atractylodis pill reaches up to 95% and above.

The invention belongs to the technical field of Chinese patent medicines, and particularly relates to a medicine for treating cervical spondylosis. Zedoary, radix clematidis, common clubmoss herbs, garden balsam stems, the roots of kudzu vine, calcined oyster shells, fried the bark of eucommia, pseudo-ginseng and herba aristolochiae serve as raw materials, preparing is completed with the conventional powder preparing method, and a preparing method specifically includes the steps that all medicines by weight are mixed to be even to be ground into fine powder with 120 meshes, then subpackaging is carried out, and the medicine for treating cervical spondylosis is obtained. Other dosage forms can be concentrated and processed based on the powder. According to the medicine, a traditional Chinese medicine preparation capable of recovering qi-blood circulation and improving sclerotin metabolism is provided, and the theory and the clinical verification show that the traditional Chinese medicine preparation is safe, nontoxic and remarkable in curative effect, the clinical effective rate is up to 99%, and the curing rate is 86.9%.

The invention belongs to the technical field of Chinese patent medicine and in particular relates to a drug for treating diabetes mellitus. The drug is prepared by taking agrimonia pilosa, radix ophiopogonis, radix astragali seu hedysari, fructus schisandrae, radix notoginseng, herba dendrobii, radix puerariae, rhodiola and radix trichosanthis as raw materials according to a conventional powder preparation method. The drug is specifically prepared through the steps of uniformly mixing all the medicines in parts by weight, grinding into fine powder with the size of 120 meshes, and sub-packaging. Other dosage forms are processed through concentrating on the basis of the powder. Theoretical and clinical tests show that the traditional Chinese medicine preparation for adjusting glucose metabolism, provided by the invention, is safe, has no toxin and has a remarkable curative effect; the drug also has the advantages of simplicity in preparation, wide medicine sources, low cost and the like, and particularly has a very good effect on the initial stage of diabetes mellitus. The clinical efficiency is up to 100 percent and the curing rate reaches 70 percent.

The invention discloses a traditional Chinese medicine composition for wind-cold treatment. The traditional Chinese medicine composition is prepared from 8-10g of Radix et Rhizoma Araliae Cordatae, 8-10g of Radix Libanotidis Buchtormensis, 8-10g of Herba Rabdosiae Ternifoliae, 4-6g of Caulis Entadae, 8-10g of Allium Splendens, 8-10g of Herba Pteridis Multifidae and 3-5 Fructus Jujubae. The traditional Chinese medicine composition for wind-cold treatment is simple and reasonable in preparation, extensive in source, low in cost, remarkable in curative effect and free of toxic and side effects, and the effective rate of clinical application reaches 95% or above.

The present invention relates to an acid amino acid double salt or composition medicine of buxenine and analogues for curing angiocardiopathy and cerebrovascular disease. The described medicine composition includes (by weight portion) 1 portion of buxenine (and its analogues) and 0.01-100 portions of G (G is alkaline amino acid, namely one of glutamic acid and asparagic acid, etc. or their mixture), and the rest is medicinal auxiliary material. Said medicine composition can be made into various dosage forms of powder injection, liquor injection, oral solution, capsule, tablet, dripping pill and others.

The invention discloses a traditional Chinese medicine formula for treating acnes. The traditional Chinese medicine formula for treating acnes is as follows: 8g to 12g of white mulberry root-bark, 8gto 12g of mulberry leaf, 8g to 12g of loquat leaf, 8g to 12g of Chinese arborvitae twig, 12g to 18g of rehmannia root, 12g to 18g of figwort root, 8g to 12g of Chinese goldthread rhizome, 8g to 12g ofmedicinal rhubarb root and rhizome, 8g to 12g of epimedium herb, 8g to 12g of rice bean, 8g to 12g of liquorice root and 28g to 32g of spreading hedyotis herb. When the traditional Chinese medicine formula is applied to treat refractory acnes, the effect is significant, the acnes cannot easily recur, the traditional Chinese medicine formula does not have obvious toxic and side effects, the priceis low, the method is simple and easy to implement, and patient compliance is high.

The invention particularly relates to an alcohol effect relieving beverage for tonifying and boosting liver and kidney and a preparation method of same. The beverage is prepared from raw materials including mature vinegar, honey, radix rehmanniae praeparata, raw hawthorns, Chinese wolfberries, white chrysanthemum, kudzu root flowers, raw ginger, mung bean powder and schisandra chinensis, wherein the amount of honey and mature vinegar can be adjusted according to preference of different people. The raw materials are soaked in pure water for 30 min, and then are decocted twice; finally the two decoctions are blended to prepare the beverage. The beverage is designed on the basis of the principle of affinal drug and diet, and is safe and toxic-free, has pleasant taste and is convenient to drink. Through functions of soothing liver to remove toxin, boosting Qi to nourishing essence, clearing heat and draining dampness, and tonifying spleen and fortifying stomach, the beverage can enhance the toxin removal function of human body. The beverage can reduce damage on human body due to the alcohol effect, protect important organs, such as liver, brain and kidney, and accelerate the metabolismand discharge of alcohol, and can prevent complications caused by the alcohol. The beverage, for long-time heavy drinkers, can reduce dependency on alcohol and relieve hypomnesia. A large amount of clinical practices and theoretical repeated verification show that the beverage can reach 98% in clinical effective rate.

The invention discloses a compound Chinese medicine for preventing and treating atrial fibrillation, which belongs to the technical field of traditional Chinese medicine; the raw materials of the compound Chinese medicine include tangerine peel, pinellia, bamboo rutabaga, citrus aurantium, scutellaria baicalensis, Bupleurum radix, Radix Paeoniae Alba, roasted licorice, flavescens, Gansong, silkworm, mulberry, salvia, cooked notoginseng, cassia twig, keel and oyster; the compound Chinese medicine of the present invention can inhibit the occurrence and development of atrial fibrillation from multiple channels and multiple targets, and can improve the autonomic nervous system of atrial fibrillation. Activation, oxidative stress, fibrosis and prethrombotic state have good therapeutic effects on atrial fibrillation of phlegm and blood stasis type, can significantly improve the frequency and duration of atrial fibrillation, and the clinical effective rate is as high as 86%; and adopt the present invention The recurrence rate of atrial fibrillation treated by the compound Chinese medicine is low, and the three-month conversion maintenance rate is 80%; meanwhile, the compound Chinese medicine of the present invention is used to treat atrial fibrillation without obvious toxic and side effects and adverse reactions.

The invention discloses a traditional Chinese medicine for treating nervous headache. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 10-20 parts of chamomile flowers, 10-15 parts of semen cassiae, 8-12 parts of fructus evodiae, 4-6 parts of bamboo shavings, 10-20 parts of ligusticum wallichii, 8-12 parts of gastrodia elata, 8-12 parts of asarum, 5-10 parts of rhizoma corydalis, 4-6 parts of fructus viticis, 5-10 parts of cassia twigs, 5-15 parts of broadleaf holly leaves, 5-10 parts of solidago decurrens, 4-6 parts of jasminum lanceolarium, 1-3 parts of ostericum sieboldii, 5-7 parts of common fenugreek seed, 4-6 parts of radix cynanchi panicullati, 5-15 parts of radix angelicae, 8-12 parts of pseudo-ginseng, 13-17 parts of kudzu vine roots, 8-12 parts of radix paeoniae alba, 5-10 parts of salsola collina and 4-6 parts of philadelphus root bark. The traditional Chinese medicine is convenient to take, and can be used for effectively treating nervous headache. The medicinal materials are combined to achieve the effects of tonifying kidneys, nourishing liver, dredging channels, relieving pain, promoting qi circulation and blood circulation, inducing resuscitation, tranquilizing and calming mind. The traditional Chinese medicine has quick response, good curative effect, small toxic and side effects and low recurrence rate, and has a clinical effective rate of 97.5 percent.

The invention discloses an efficient medicine composition without toxic and side effects for treating wind-cold. The efficient medicine composition comprises 12-14g of Chinese elm barks, 8-10g of Chinese lobelia herbs, 13-15g of hydrous Chinese ligusticum rhizomes, 4-6g of narrowleaf screwtree herbs, 8-10g of aster auriculatus Franch, 3-5g of barbed skullcap herbs, 8-10g of fig receptacles and 3-5g of alum. The medicine composition for treating wind-cold is simple in preparation, reasonable, wide in medicine source, low in cost, remarkable in curative effect and free from toxic and side effects, and the effective rate of clinical application reaches up to 94% or more.

The invention discloses a black rice health-preserving wine capable of tonifying kidney and producing sperm and a production method thereof, belonging to the technical field of health food brewage. The production method comprises the following steps: adding a traditional Chinese medicinal material extracting solution capable of tonifying kidney before aging and storing black rice wine, aging and storing, settling, filtering and sterilizing. The wine is prepared from the following raw materials in parts by weight: 100 parts of black rice wine, 1.0-1.5 parts of Diaphragma juglandis, 1.2-1.5 parts of radix astragali, 2.0-2.5 parts of Polygonatum sibiricum, 0.8-1.0 part of licorice, 0.5-0.9 part of American ginseng, 0.5-0.6 part of angelica, 0.6-0.9 part of orange peel, 0.6-0.9 part of skunk bugbane, 0.7-0.9 part of Bighead Atractylodes Rhizome, 0.4-0.5 part of ginger, 0.5-1.0 part of Chinese date and 0.5-1.0 part of Chinese wolfberry. The total flavone content in the produced black rice wine reaches 178.52 mg / 100ml. The clinical use proves that the black rice wine has obvious actions on dizziness, tiredness, waist soreness, leg pain and nocturia caused by deficiency and aging of the kidney, has no toxic or side effect, and is suitable for broad people.

The invention discloses radix bupleuri liver-soothing powder for treating melancholia. The raw materials of the radix bupleuri liver-soothing powder for treating melancholia comprise the following components: 6 to 8 parts of vinegar-processed adix bupleuri, 6 to 8 g of astragalus membranaceus, 6 to 8 g of dry perilla leaves, 6 to 8 g of dried orange peel, 6 to 8 g of ligusticum chuanxiong Hort, 8 to 10 g of rhizoma cyperi, 8 to 10 g of fried fructus aurantii, 8 to 10 g of white paeony root, 8 to 10 g of honey-fried licorice root and 6 to 8 g of Chinese angelica. The radix bupleuri liver-soothing powder for treating melancholia, provided by the invention, is simple and reasonable in preparation, wide in medicine source, low in cost and remarkable in curative effect, does not have toxic or side effect, has the effects of soothing liver and relieving depression, and can effectively treat melancholia; the clinical application effective rate is up to 95 percent or above.

The invention discloses ginseng toxin-vanquishing powder for treating dysentery. The raw materials of the ginseng toxin-vanquishing powder for treating dysentery comprise the following components: 10 to 12 g of radix bupleuri, 10 to 12 g of ginseng, 4 to 6 g of liquorice, 10 to 12 g of ligusticum chuanxiong Hort, 10 to 12 g of fructus aurantii, 10 to 12 g of notopterygium root, 10 to 20 g of radix sileris, 13 to 15 g of poria cocos, 10 to 20 g of radix sileris and 10 to 20 g of fructus forsythia. The ginseng toxin-vanquishing powder for treating dysentery, provided by the invention, is simple and reasonable in preparation, wide in medicine source, low in cost and remarkable in curative effect, and does not have toxic or side effect; the clinical application effective rate is up to 95 percent or above.

The invention discloses a medicine composition for rapidly treating wind-cold. The medicine composition comprises 12-14g of needle spikesedge herbs, 8-10g of common stelmatocrypton herbs, 8-10g of hydrous Chinese ligusticum rhizomes, 4-6g of hydrous siebold wildginger herbs, 8-10g of aster auriculatus Franch, 3-5g of ternate pinellia rhizome, 8-10g of fig receptacles and 3-5g of notopterygium incisium. The medicine composition for rapidly treating wind-cold is simple in preparation, reasonable, wide in medicine source, low in cost, remarkable in curative effect and free from toxic and side effects, and the effective rate of clinical application reaches up to 96% or more.

The invention discloses a preparation method for a medicine ink block. The preparation method comprises the following steps: selecting more than twenty traditional Chinese medicine of cornu bubali concentrated powder, cornu antelops, musk, borneol, pearl, toad venom, and the like as herbs; conducting procedures of extraction, superfine smashing, stirring for mixing, sterilizing, drying, pressing for forming, and the like on the herbs to obtain the medicine ink block. The preparation method is fine in technology; the prepared herbs are remarkable in curative effect on various skin, oral cavity and throat chronic diseases, such as ichthyosis, chronic eczema, chronic urticaria, shingles, neurodermatitis, stubborn dermatitis, acne, bottle nose unknown pyogenic infection, chronic pharyngitis, and relapsing oral ulcer.

The invention discloses a traditional Chinese medicine for treating measles. The traditional Chinese medicine comprises 6-8 g of rhizoma cimicifugae, 7-9 g of Chinese herbaceous peony, 16-18 g of root of kudzu vine, 8-10 g of fructus forsythiae, 7-9 g of divaricate saposhnikovia root, 6-8 g of prepared radix licorice, 6-8 g of cassia twigs and 5-7 g of arnebia root. The traditional Chinese medicine has the advantages of simple and reasonable preparation processes, wide drug sources, low cost, prominent curative effect, no toxic or side effect, effects of relieving the exterior syndrome with drugs pungent in flavor and cool in property, resolving flesh and promoting eruption, and clinical application efficiency of 95% or more.

A nourishing yin and beneficial oral liquid for treating radioactive xerostomia belongs to the technical field of traditional Chinese medicine. Combining, then placing each raw material in an extraction tank, adding distilled water, heating with high heat to boiling, changing to simmering fire, maintaining slight boiling for 40-60 minutes, filtering, and concentrating the filtrate to 0.25-0.75 times the total weight of the original medicinal material to make Its beneficial effects are that Sha participates in Ophiopogon japonicus as the monarch medicine, nourishing yin and moistening dryness, clearing the lungs and quenching thirst; Tujia characteristic cucumber fragrance and nine head lion grass are the minister medicines, clearing away heat and detoxifying, cooling blood and reducing swelling; Pueraria lobata, lily, Polygonatum japonica is an adjuvant, mainly clearing heat and promoting body fluid, moistening lungs and nourishing yin; licorice is used as an agent to reconcile various medicines; it can nourish yin and nourish yin for the symptoms of radioactive xerostomia, such as dry mouth, dry mouth, dry lips, and glossy tongue. Promotes body fluid, clears heat and detoxifies; greatly reduces the exudation area, ulcer area and congestion area of ​​radioactive xerostomia.

The invention discloses a traditional Chinese medicine composition for treating chronic appendicitis. The traditional Chinese medicine composition comprises, by weight, 8-10 parts of rheum officinale, 5-6 parts of peach seed, 1-3 parts of white peony root, 5-6 parts of tree peony bark, 3-5 parts of coix seed, 2-4 parts of patrinia herb, 6-8 parts of pangolin, 3-4 parts of curcuma rhizome, 1-3 parts of caulis clematidis armandii, 5-8 parts of dandelion, 3-4 parts of hedyotis diffusa, 2-4 parts of corydalis tuber, 12-15 parts of honeysuckle flower, 20-25 parts of wax gourd seed, 5-6 parts of radix bupleuri, 3-4 parts of folium isatidis, 2-4 parts of cynanchum paniculatum, 2-3 parts of shiny cinquefoil root and 1-2 parts of olive nut. The traditional Chinese medicine composition is designed according to a traditional Chinese medicine differentiation theory. Through compatibility of medicines, the traditional Chinese medicine composition has effects of rectifying qi and promoting blood circulation, warming cold-damp, strengthening spleen and stomach and effectively treating chronic appendicitis, realizes simultaneous treatment of principal and subordinate symptoms, has no side effect and has clinical efficiency of 98.2%.

The invention discloses a pharmaceutical composition for wind-cold treatment. The pharmaceutical composition is prepared from 12-14g of Semen Momordicae, 8-10g of Radix Stephaniae Delavayi, 8-10g of Rhizoma Coptidis, 4-6g of Radix Stephaniae Cepharanthae, 8-10g of Herba Potentillae Chinensis, 8-10g of Allium Caelureum and 3-5g of Rhizoma et Radix Notopterygii. The pharmaceutical composition for wind-cold treatment is simple and reasonable in preparation, extensive in source, low in cost, remarkable in curative effect and free of toxic and side effects, and the effective rate of clinical application reaches 95% or above.

The invention discloses an agent for treating women's acute mastitis. The agent is mainly prepared from the following raw material medicines in parts by weight: 8-12 parts of fried cape jasmine, 9-15 parts of baked ginger, 6-9 parts of sunglo, 6-9 parts of fenugreek, 8-16 parts of stellaria yunnanensis, 9-15 parts of chickweed, 3-6 parts of silkworm larva, 4-8 parts of selfheal, 5-10 parts of kelp, 10-20 parts of caulis bambusae in taeniam, 8-16 parts of cuttlebone, 9-16 parts of fructus aurantii, 10-20 parts of rhizoma anemarrhenae, 5-12 parts of rhizoma sparganii, 8-16 parts of eleusine indica and 8-14 parts of curcuma zedoary. The agent disclosed by the invention is scientific in formula and strict in formula, has the effects of clearing away heat and toxic materials, soothing the liver and regulating qi and promoting lactation and eliminating stagnation and is low in preparation cost, good in curative effect and fast to take effect, and the clinical effective rate is 98.2 percent.

The invention relates to the field of traditional Chinese medicine preparations, and in particular to a medicinal composition for treating mammary gland fibroma and a preparation method and application thereof. The medicinal composition for treating mammary gland fibroma comprises Chinese wolfberry, poria cocos, pollen pini, raspberry, agastache rugosus, mint, hawthorn, witloof, lotus seeds and lotus leaves as raw materials. The raw materials are all raw materials for both medicines and foods, that is, the raw materials are both foods and medicines selves, with matching of properties of the raw materials and effective components, an effect of treating mammary gland fibroma is achieved, a very good treatment effect is achieved, the clinical effective rate of the medicinal composition is as high as 100%, the effect taking time is relatively short, and disease reoccurrence can be effectively avoided.

The invention discloses a traditional Chinese medicine for treating a cold. The traditional Chinese medicine is prepared from the following raw materials by weight: 8-10 g of herba ephedra, 8-10 g of radix paeoniae alba, 8-10 g of fructus schisandrae, 8-10 g of rhizoma zingiberis, 8-10 g of honey-fried licorice root, 8-10 g of cassia twig, 8-10 g of rhizoma pinelliae, 8-10 g of radix asteris, 5-7 g of radix platycodi, and 4-6 g of herba asari. For the traditional Chinese medicine for treating the cold, the preparation is simple and reasonable, the medicinal materials are easily available, the cost is low, the curative effects are obvious, no toxic and side effects exist, the traditional Chinese medicine also has the efficacies of exterior syndromes and dispelling cold, and warming the lung to reduce watery phlegm, and the clinical application shows that the effective rate achieves 95% or above.